C. Kent Osborne, MD: Breast Cancer Treatment – A Year In Review
Dr. C. Kent Osborne, the co-director of the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), discusses breast cancer advances and treatment highlights over the past year. He highlights three areas which he thinks will be practice changing: the overall treatment of HER2-positive breast cancer, the findings from the BOLERO-2 trial and the use of bisphosphonates in breast cancer treatment and prevention.
Dr. Osborne is professor of Medicine and Molecular and Cellular Biology, director of the Dan L. Duncan Cancer Center and the Smith Breast Center at Baylor College of Medicine and acting chief of the section of Hematology-Oncology at Baylor College of Medicine.
The Group Room at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium was made possible by support from:
Comments
Leave a Reply
OUR PARTNERS
